Response to the Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial"

Ann Surg. 2020 May;271(5):e122. doi: 10.1097/SLA.0000000000003675.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Hypertension, Portal*
  • Somatostatin*
  • Transplant Recipients

Substances

  • Somatostatin